Skip to content

Percentage Venous Options in Pediatrics & Adults

Utilizing a Near Infrared Vein Visualization Device To Increase Peripheral Intravenous Access Targets in Pediatric & Adult Patients (% Venous Options)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01453335
Enrollment
300
Registered
2011-10-17
Start date
2011-06-30
Completion date
2011-12-31
Last updated
2011-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Veins

Keywords

Veins, Catheter Segments, Vascular Access, VeinViewer Vision

Brief summary

VeinViewer® Vision will significantly increase the number of peripheral intravenous catheter access targets perceived by clinicians with experience in intravenous cannulation when compared to the number of access targets that these clinicians are able to visualize unaided or to palpate.

Interventions

None listed

Sponsors

Christie Medical Holdings, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Pediatric arm Inclusion Criteria: * Age 17 years of age or younger, * Intact skin, without rash,irritation, scarring, open abrasion or other injury in these sites. * Parent or guardian is English speaking * Pediatric patients 8 years older will be asked to provide assent * Participant does not have an acute or critical medical illness or injury requiring immediate evaluation and/or treatment.

Exclusion criteria

* 18 years of age or older * No intact upper extremities * Patient has had current or recent (within 6 months) venous access in the arm that will be evaluated. * Acute or critical illness or injury requiring immediate or urgent evaluation and treatment. Adult arm: Inclusion Criteria: * Age 18 years or older, * At least one intact upper extremity (intact from the base knuckle to the shoulder) * Intact skin on the dorsum of the hand, the ventral forearm, and antecubital fossa, without rash, irritation, scarring, open abrasion or other injury in these sites. * Participant does not have an acute or critical medical illness or injury requiring immediate evaluation and/or treatment.

Design outcomes

Primary

MeasureTime frame
Number of Veins Identified with VeinViewer will be greater than those identified by sight or sight & palpationImmediately after assessment-Day 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026